Citations

Clear

2416 citation(s) found for "Yu, Jason".

Intercostal Nerve Blocks Using Liposomal Bupivacaine
Höfer, R , Rosenberg, Casandra, Niesen, Adam D. , Eldrige, Jason S. , Amundson, Adam W.

Mayo Clinic

Anaesthesia Cases | October 31, 2016 | Volume: 3 | Issue: 1 | Pages: 34-37

10.21466/ac.inbulb2.2015 Get It

SummaryA 51‐year‐old male was admitted to the intensive care unit following a cardiac arrest during which he received chest compressions and suffered rib fractures. The patient's condition subsequently improved and tracheal extubation was eventually planned. However, he was unable to tolerate spontaneous breathing trials due to pain from his rib fractures. Systemic analgesia provided either insufficient pain control or over‐sedation. Neuraxial techniques were contraindicated as he was receiving systemic anticoagulation and antiplatelet medications. Intercostal nerve blocks with liposomal bupivacaine were performed under ultrasound guidance without complications. Approximately six hours after the injections, the patients trachea was successfully extubated with no further need for respiratory support through to discharge. In appropriately selected patients, intercostal nerve blocks with liposomal bupivacaine can adequately treat pain from rib fractures and improve respiratory mechanics.
Regarding the Safety of Interventional Pain Procedures in the Setting of Anticoagulation
Moeschler, Susan M. , Eldrige, Jason S. , Warner, Nafisseh S.

Mayo Clinic

Pain Medicine | October 27, 2016 | Volume: 18 | Issue: 4 | Pages: 819-820

10.1093/pm/pnw253 | PMID 28034976 Get It

Pruritic Waxy and Verrucous Papules in a Middle-Aged Man
Sluzevich, Jason C. , Hoesly, Paul M. , Sluzevich, Jason C

Mayo Clinic

JAMA Dermatology | October 26, 2016 | Volume: 153 | Issue: 2 | Pages: 221

10.1001/jamadermatol.2016.3602 | PMID 27784044 Get It

Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression
Tang, Chih-Min, Lee, Tracy E., Syed, Sabriya A. , Burgoyne, Adam M. , Leonard, Stephanie Y., Chan, Jonathan C., Shi, Eileen, Chmielecki, Juliann , Morosini, Deborah, Wang, Kai , Kendrick, Michael L. , Bardsley, Michael R., Siena, Martina De , Mao, Junhao , Ördög, Tamás , Gao, Fei , Ross, Jeffrey S , Harismendy, Olivier , Sicklick, Jason Keith , De Siena, Martina

Mayo Clinic

Oncotarget | October 26, 2016 | Volume: 7 | Issue: 48 | Pages: 78226-78241

10.18632/oncotarget.12909 | PMID 27793025 Get It

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Mace, Thomas A. , Shakya, Reena, Pitarresi, Jason R. , Swanson, Benjamin , McQuinn, Christopher, Loftus, Shannon , Nordquist, Emily , Cruz‐Monserrate, Zobeida , Young, Gregory , Zhong, Xiaoling , Zimmers, Teresa A. , Ostrowski, Michael C. , Ludwig, Thomas , Bloomston, Mark , Bekaii‐Saab, Tanios , Yu, Lianbo , Lesinski, Gregory B , Bekaii-Saab, Tanios S

Mayo Clinic

Gut | October 21, 2016 | Volume: 67 | Issue: 2 | Pages: 320-332

10.1136/gutjnl-2016-311585 | PMID 27797936 Get It

Objective Limited efficacy of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDAC) has prompted investigation into combination therapy. We hypothesised that interleukin 6 (IL-6) blockade would modulate immunological features of PDAC and enhance the efficacy of anti-programmed death-1-ligand 1 (PD-L1) checkpoint inhibitor therapy. Design Transcription profiles and IL-6 secretion from primary patient-derived pancreatic stellate cells (PSCs) were analyzed via Nanostring and immunohistochemistry, respectively. In vivo efficacy and mechanistic studies were conducted with antibodies (Abs) targeting IL-6, PD-L1, CD4 or CD8 in subcutaneous or orthotopic models using Panc02, MT5 or KPC-luc cell lines; and the aggressive, genetically engineered PDAC model (Kras LSL−G12D , Trp53 LSL−R270H , Pdx1-cre, Brca2 F/F (KPC-Brca2 mice)). Systemic and local changes in immunophenotype were measured by flow cytometry or immunohistochemical analysis. Results PSCs (n=12) demonstrated prominent IL-6 expression, which was localised to stroma of tumours. Combined IL-6 and PD-L1 blockade elicited efficacy in mice bearing subcutaneous MT5 (p<0.02) and Panc02 tumours (p=0.046), which was accompanied by increased intratumoural effector T lymphocytes (CD62L − CD44 − ). CD8-depleting but not CD4-depleting Abs abrogated the efficacy of combined IL-6 and PD-L1 blockade in mice bearing Panc02 tumours (p=0.0016). This treatment combination also elicited significant antitumour activity in mice bearing orthotopic KPC-luc tumours and limited tumour progression in KPC-Brca2 mice (p<0.001). Histological analysis revealed increased T-cell infiltration and reduced α-smooth muscle actin cells in tumours from multiple models. Finally, IL-6 and PD-L1 blockade increased overall survival in KPC-Brca2 mice compared with isotype controls (p=0.0012). Conclusions These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.
F4‐02‐04: The Alzheimer's Prevention Initiative (API) Program: Genetic Testing and Disclosure Strategies
Karlawish, Jason , Bradbury, Angela R. , Wood, Elisabeth, Roberts, J. Scott , Patrick‐Miller, Linda , Blacker, Deborah, Caselli, Richard J. , Marchant, Gary E. , Zallen, Doris T. , Langlois, Carolyn, Walsh, Trisha, Gordon, David , Reiman, Eric M. , Tariot, Pierre N. , Langbaum, Jessica B. S. , Wood, Elisabeth McCarty , Kim, Scott Y. H. , Patrick‐Miller, Linda , Blacker, Deborah

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_6 | Pages: No page available

10.1016/j.jalz.2016.06.595 Get It

F5‐02‐03: BDNF VAL66MET Moderates Cognitive Impairment, Neuronal Dysfunction and TAU in Preclinical Autosomal Dominant Alzheimer's Disease
Fagan, Anne M. , Benzinger, Tammie Lee Smith, Ricardo, Allegri, Chhatwal, Jasmeer P. , Farlow, Martin R. , Graff‐Radford, Neill R. , Laske, Christoph , Ringman, John M. , Salloway, Stephen , Lim, Yen Ying , Hassenstab, Jason , Cruchaga, Carlos , Goate, Alison , Benzinger, Tammie L.S. , Maruff, Paul , Snyder, Peter J. , Masters, Colin L. , Allegri, Ricardo , Xiong, Chengjie , McDade, Eric , Rossor, Martin N. , Schofield, Peter William , Holtzman, David M. , Morris, John C. , Bateman, Randall J.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2016.06.689 Get It